Prognostic significance of defective mismatch repair and BRAF V600E in patients with colon cancer. - Wikidata - awgldk - TriplyDB

Prognostic significance of defective mismatch repair and BRAF V600E in patients with colon cancer.

Prognostic significance of defective mismatch repair and BRAF V600E in patients with colon cancer.

http://www.wikidata.org/entity/Q37173288

about

Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease Molecular approach to genetic and epigenetic pathogenesis of early-onset colorectal cancer cfDNA analysis from blood in melanoma BRAF mutant colorectal cancer as a distinct subset of colorectal cancer: clinical characteristics, clinical behavior, and response to targeted therapies Toward a Molecular Classification of Colorectal Cancer: The Role of BRAF Are KRAS/BRAF mutations potent prognostic and/or predictive biomarkers in colorectal cancers?Prognostic and predictive markers in stage II colon cancer: is there a role for gene expression profiling?Molecular alterations and biomarkers in colorectal cancer BRAFV600E mutation and its association with clinicopathological features of colorectal cancer: a systematic review and meta-analysis.Tumour biomarkers: homeostasis as a novel prognostic indicator Impaired coordination between signaling pathways is revealed in human colorectal cancer using single-cell mass cytometry of archival tissue blocks Prognostic impact of FoxP3+ regulatory T cells in relation to CD8+ T lymphocyte density in human colon carcinomas.BRAFV600E immunohistochemistry in conjunction with mismatch repair status predicts survival in patients with colorectal cancer.Prognostic and predictive value of TOPK stratified by KRAS and BRAF gene alterations in sporadic, hereditary and metastatic colorectal cancer patients.BRAF mutations, microsatellite instability status and cyclin D1 expression predict metastatic colorectal patients' outcome.A cohort study of cyclin D1 expression and prognosis in 602 colon cancer cases.The evolution of colorectal cancer genetics-Part 2: clinical implications and applications Cathepsin B expression and survival in colon cancer: implications for molecular detection of neoplasia.The prognostic value of BRAF mutation in colorectal cancer and melanoma: a systematic review and meta-analysis.Prognostic and predictive response factors in colorectal cancer patients: between hope and reality.Prognostic Impact of Deficient DNA Mismatch Repair and Mutations in KRAS, and BRAF(V600E) in Patients with Lymph Node-Positive Colon Cancer BRAF mutation is a powerful prognostic factor in advanced and recurrent colorectal cancer Review of histopathological and molecular prognostic features in colorectal cancer MTHFR Glu429Ala and ERCC5 His46His polymorphisms are associated with prognosis in colorectal cancer patients: analysis of two independent cohorts from Newfoundland.Mutation profiling and microsatellite instability in stage II and III colon cancer: an assessment of their prognostic and oxaliplatin predictive value Association between molecular subtypes of colorectal cancer and patient survival SPARCL1, Shp2, MSH2, E-cadherin, p53, ADCY-2 and MAPK are prognosis-related in colorectal cancer Prognostic value of KRAS and BRAF mutations in curatively resected colorectal cancer DNA mismatch repair status and colon cancer recurrence and survival in clinical trials of 5-fluorouracil-based adjuvant therapy.KRAS and BRAF gene mutations and DNA mismatch repair status in Chinese colorectal carcinoma patients Deciphering genomic alterations in colorectal cancer through transcriptional subtype-based network analysis Prognostic role of microRNA-21 in colorectal cancer: a meta-analysis.BRAFV600E mutation analysis in patients with metastatic colorectal cancer (mCRC) in daily clinical practice: correlations with clinical characteristics, and its impact on patients' outcome.Microsatellite instability and mutations in BRAF and KRAS are significant predictors of disseminated disease in colon cancer.Cancerous inhibitor of protein phosphatase 2A (CIP2A) is an independent prognostic marker in wild-type KRAS metastatic colorectal cancer after colorectal liver metastasectomy Colorectal carcinomas with KRAS codon 12 mutation are associated with more advanced tumor stages Cancer immunology--analysis of host and tumor factors for personalized medicine.Prognostic and predictive biomarkers in resected colon cancer: current status and future perspectives for integrating genomics into biomarker discovery.Distinct Clinicopathological Patterns of Mismatch Repair Status in Colorectal Cancer Stratified by KRAS Mutations.Specific activity of cyclin-dependent kinase I is a new potential predictor of tumour recurrence in stage II colon cancer

P2860

Q24289344-1010BDAF-56D0-4AD7-8402-19C320BCEE7F Q26769935-DADAA5DC-9DCF-44C0-9FBE-FFC1BC50E3F7 Q26772199-767E7CBF-7DF7-465E-9B87-5CE901368D56 Q26772276-EEE28C29-302B-4A7B-AD04-D95A8375A404 Q26827212-A545F9B7-8402-4D4A-90FD-D143B8CE7F27 Q26828992-33B81EC4-34DC-4C1E-A42A-798607492A5F Q26830362-3E748006-A4EF-4083-890B-FB915929B4D1 Q26862317-305F6EA9-7CE6-45FF-8D92-C9351896FB79 Q27852942-7E23266A-A84C-413B-9D1B-E70ECD321010 Q28069898-4473D63A-9639-4367-A71A-52A15829D66F Q30358990-5CC8A44E-65AF-423A-A255-B1047F4D2A84 Q31081979-B2A1C7D9-61A3-4857-9641-CA25C9913E53 Q33615076-9FDDF5B7-9F40-4623-9AAA-D46868783804 Q33620070-0C135460-9710-48EC-8DB9-4E92B6A3B107 Q33906044-6F0F5244-E598-4CDB-8F5B-12D25ABE8A65 Q34066685-5C804067-BEF6-4858-961E-5AC34A704401 Q34234950-B29A27D4-DA2E-4327-95C4-AC9F64F607FF Q34292820-603AF74A-5E44-4A82-9640-3EDE4AF841BD Q34442771-1FA6C5E5-607D-4CE1-9229-557BE158B71B Q34467133-7F333D01-43D0-4D0A-A0B1-E5B5AA1AB39A Q34472453-8EEB172C-B375-4716-9220-245B8E8EA882 Q34621860-32D89BF9-F5B8-494B-A9D4-A7A7940BAC6A Q34657323-3F911AF5-916A-4037-9654-F78DD1B53AF2 Q34692175-48DBA075-7769-440C-8F52-2818A180355F Q34755943-68317A2B-C6D4-402E-94D2-487E027DCC5F Q34759064-5F344F9B-516E-4B76-8551-18988D91C95D Q34863399-596D92B0-7D6C-4834-AC48-FBE6EBA43300 Q35012132-7773D8A1-F195-4837-B42C-A34D73F3B93B Q35031411-5DA559FA-0844-4AEC-BF09-B59319C0EBD6 Q35045790-BB95CF28-FB95-4442-867B-2E3B720F807E Q35048299-FBF5DC42-B322-432E-93D6-24D3FBE59925 Q35050650-F7AB8646-88DA-44A5-8E1A-778B23AFDC36 Q35075820-5A4C7F41-0231-476C-B9D8-C03159BD5248 Q35191237-081F3C31-6EB1-4888-B0B0-AE779BF60B48 Q35503680-707FEA50-C76C-4351-83FF-1C64B631E9A0 Q35579056-572D753B-D3A4-4B0D-9AC2-EC5C09C56075 Q35583180-9EF34BAC-F5C6-4E09-AA4E-7CE15672701C Q35583987-41329355-83C3-4101-836C-D247D941B84D Q35652713-FC2BC190-3013-432C-9F62-22A92FF92D4C Q35653762-30F0E28A-76C1-4D53-B68C-C4AB2EEC496C

P2860

Prognostic significance of defective mismatch repair and BRAF V600E in patients with colon cancer.

http://www.wikidata.org/entity/Q37173288

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on June 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Prognostic significance of def ...... in patients with colon cancer.

@en

Prognostic significance of def ...... in patients with colon cancer.

@nl

type

label

Prognostic significance of def ...... in patients with colon cancer.

@en

Prognostic significance of def ...... in patients with colon cancer.

@nl

prefLabel

Prognostic significance of def ...... in patients with colon cancer.

@en

Prognostic significance of def ...... in patients with colon cancer.

@nl

P1433

Q37173288-757C7C59-BA5E-47B1-8FEA-8CCE3C115950

P1476

Q37173288-519F1FEC-76E6-4DDD-AAEA-9B426EECEC0E

P2093

Q37173288-0D35ABEC-47FD-4047-9A9C-C880631D517A

Q37173288-387EE285-5E42-4E80-8FEF-461DE81B3982

Q37173288-8A0402D1-1D69-4058-B571-23FC6F896006

Q37173288-8FCFF5D4-614A-4FB2-B0D1-EA37EE0E0167

Q37173288-9CC897CD-5AE4-4F89-830C-9388D4ADC08A

Q37173288-C0FFFB92-58AB-45D6-96D0-84D13544617E

Q37173288-D2B15E64-5A95-4AD7-B83A-9B5E6ABB0AB4

Q37173288-EDA71DFD-A655-4BFB-8FF7-B02A778148FB

P2860

Q37173288-05D52145-F1F8-4FB5-81E7-E1740E2300E3

Q37173288-0A982EBA-64C1-4E51-8BB3-EC55185E6D37

Q37173288-0EB90E20-937E-435B-8832-4416B02039FC

Q37173288-1214B577-F723-4415-B0FE-24C31CCD9B13

Q37173288-17B55676-D9CF-41F5-8C51-AF7DCD30317F

Q37173288-331EB15F-C9E2-47F4-80ED-043AC4ED30E8

Q37173288-41408F15-2996-4A33-B539-F4A5C9632CED

Q37173288-41BB726E-74B9-4372-A820-E52F588ED2DB

Q37173288-4E1BDBC5-DB92-4116-AB22-81F77BED905D

Q37173288-56AF4B97-CD04-4F18-9CBD-9768ABCFC3BB

P304

Q37173288-04B92B4B-BD4F-460D-96B3-F357F3147C5C

P31

Q37173288-213A7E13-56B5-4B26-8F30-0958A8A1713C

P356

Q37173288-81E088E4-5E84-43B8-9EEE-3E778FA9E8DA

P407

Q37173288-F0236BE5-3C6B-4067-959C-983011342DAF

P433

Q37173288-E748A3BD-8572-490E-A1CD-A521870DC1F5

P478

Q37173288-3A432617-F4E7-4C60-BFCB-2EDCD4E396EA

P50

Q37173288-86E1705D-8CB7-479B-AE63-A2C801D7867D

P577

Q37173288-6326EA5C-F9D6-41CC-9EA8-F89C1C84F888

P698

Q37173288-028054AA-B730-4A05-B5D9-2818DAE69C8D

P921

Q37173288-D31B7AD9-BDE3-4FC1-929F-61B3CD081563

P932

Q37173288-68ADD552-A9AB-4403-9D6A-21C47483E8AF

P356

1078-0432.CCR-07-1489

P1433

Clinical Cancer Research

P1476

Prognostic significance of def ...... in patients with colon cancer

@en

P2093

Amy J French

http://www.w3.org/2001/XMLSchema#string

Brian F Kabat

http://www.w3.org/2001/XMLSchema#string

Harold E Windschitl

http://www.w3.org/2001/XMLSchema#string

Lawrence J Burgart

http://www.w3.org/2001/XMLSchema#string

Lois Shepherd

http://www.w3.org/2001/XMLSchema#string

Nathan R Foster

http://www.w3.org/2001/XMLSchema#string

Richard Goldberg

http://www.w3.org/2001/XMLSchema#string

Stephen N Thibodeau

http://www.w3.org/2001/XMLSchema#string

P2860

Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer

Mutations of the BRAF gene in human cancer

BRAF mutation is frequently present in sporadic colorectal cancer with methylated hMLH1, but not in hereditary nonpolyposis colorectal cancer

Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer

Raf-1 protein kinase is required for growth of induced NIH/3T3 cells

A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer

Systematic review of microsatellite instability and colorectal cancer prognosis

CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer

Cancer statistics, 2006

Genetic instability in colorectal cancers

P304

3408-3415

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-07-1489

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

Daniel J. Sargent

P577

2008-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18519771

http://www.w3.org/2001/XMLSchema#string

P921

P932

2674786

http://www.w3.org/2001/XMLSchema#string